ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
224.46
-2.28 (-1.01%)
Aug 14, 2026, 4:00 PM EDT - Market closed

ResMed Balance Sheet

Millions USD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
1,4691,209238.36227.89273.71
Short-Term Investments
----9.17
Cash & Short-Term Investments
1,4691,209238.36227.89282.88
Cash Growth
21.48%407.40%4.59%-19.44%-4.20%
Receivables
1,036990.67875.46704.91601.64
Inventory
945.81975.96994.451,141851.2
Prepaid Expenses
416.08329.53249.45293.93195.61
Other Current Assets
457.39---0.15
Total Current Assets
4,3253,5062,3582,3681,931
Property, Plant & Equipment
735718.29699.15665.81630.5
Long-Term Investments
-139.82139.2134.1149.21
Goodwill
-3,0472,8422,7701,936
Other Intangible Assets
3,362464.86485.9552.34345.94
Long-Term Accounts Receivable
-14.5818.4510.088.84
Long-Term Deferred Tax Assets
543.9253.12203.57132.9779.75
Other Long-Term Assets
-31.44126.35118.26113.7
Total Assets
8,9668,1746,8726,7525,096

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
308.92278.16237.73150.76159.25
Accrued Expenses
494.92362.33337.89328.48316.89
Current Portion of Long-Term Debt
259.959.99.99.99.92
Current Portion of Leases
29.1430.5125.2821.9221.86
Current Income Taxes Payable
98.11132.27107.5272.2244.89
Current Unearned Revenue
162.91166.03152.55138.07108.67
Other Current Liabilities
41.1639.9339.7937.1827.84
Total Current Liabilities
1,3951,019910.66758.53689.3
Long-Term Debt
399.42658.39697.311,431765.33
Long-Term Leases
137.41153.02141.44116.85120.45
Long-Term Unearned Revenue
170.95156.8137.34119.1995.46
Long-Term Deferred Tax Liabilities
64.6477.6879.3490.659.71
Other Long-Term Liabilities
213.03141.5242.26105.3554.86
Total Liabilities
2,3812,2072,0082,6221,735

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
0.760.760.590.590.59
Additional Paid-In Capital
2,1912,0341,8971,7721,682
Retained Earnings
7,2556,0814,9924,2533,614
Treasury Stock
-2,779-2,073-1,773-1,623-1,623
Comprehensive Income & Other
-82.52-74.7-251.53-272.53-312.75
Shareholders' Equity
6,5855,9684,8644,1303,361
Total Liabilities & Equity
8,9668,1746,8726,7525,096

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Total Debt
825.92851.81873.941,580917.55
Net Cash (Debt)
643.32357.64-635.57-1,352-634.67
Net Cash Growth
79.88%----
Net Cash Per Share
4.402.43-4.31-9.17-4.32
Filing Date Shares Outstanding
144.71146.41146.93147.07146.42
Total Common Shares Outstanding
144.71146.39146.9147.06146.41
Working Capital
2,9302,4861,4471,6091,242
Book Value Per Share
45.5140.7733.1128.0822.95
Tangible Book Value
3,2232,4561,536807.261,078
Tangible Book Value Per Share
22.2716.7810.465.497.37
Land
-51.6851.9852.0651.86
Buildings
-230.63231.07231.02229.5
Machinery
-849.74889.85831.3769.07
Leasehold Improvements
-124.05102.191.580.86
SEC Filings: 10-K · 10-Q